Covid-19: Government dismisses Adar Poonawalla’s Rs 80,000 crore estimate for vaccine | Business

Sep 30, 2020, 01:41PM ISTSource: TOI.in The government on Tuesday said it has drawn estimates about Covid-19 vaccine requirement and that there are adequate resources to ensure availability to those … Read More

Don’t agree with calculation of Rs 80k cr for COVID vaccine distribution in India: Health Ministry

NEW DELHI: The government on Tuesday said it does not agree with the calculation that Rs 80,000 crore is needed for distribution of COVID-19 vaccine in India. Health Ministry Secretary … Read More

Will govt have Rs 80,000 cr for distribution of vaccine, asks Serum Institute CEO

Pune: Adar Poonawalla, Chief Executive Officer of Serum Institute of India (SII) which is producing the potential coronavirus vaccine developed by Oxford University, asked on Saturday if the government will … Read More

Will resume COVID-19 vaccine trials after DCGI nod: Serum Institute

NEW DELHI: Serum Institute of India will resume clinical trials of AstraZeneca‘s COVID-19 vaccine candidate after getting the permission from the Drugs Controller General of India (DCGI), the Pune-based vaccine … Read More

Fortune’s 40 Under 40 full list, Isha ambani, Akash Ambani, Byju Raveendran, Adar Poonawalla,

Image Source : FILE Isha, Akash Ambani, Byju Raveendran, Adar Poonawalla feature on Fortune’s ‘40 Under 40’ influencer list  Reliance Jio Board Directors Isha Ambani and Akash Ambani, Serum Institute … Read More

Serum Institute looking for a $1-b shot to fight covid, talks on with Blackstone, KKR and others

MUMBAI: Serum Institute of India (SII), the world’s largest vaccine manufacturer, is in talks with private equity investors including Blackstone and KKR as well as philanthropists and social venture funds … Read More

Oxford AstraZeneca Covishield: Will reserve enough coronavirus vaccine doses for Parsis, says Adar Poonawalla

Image Source : FILE Covishield: Will reserve enough coronavirus vaccine doses for Parsis, says Adar Poonawalla “More than enough” doses of the COVID-19 vaccine developed by Oxford University and AstraZeneca … Read More

Oxford coronavirus vaccine Covishield to reach masses India Adar Poonawalla, CEO, Serum Institute of India

Image Source : IANS Oxford Coronavirus Vaccine: I believe Covishield to reach masses by first quarter of 2021, says Poonawalla In an interview with IANS, Adar Poonawalla, CEO, Serum Institute … Read More